These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22071305)

  • 1. Rational design and synthesis of aminopiperazinones as β-secretase (BACE) inhibitors.
    Tresadern G; Delgado F; Delgado O; Gijsen H; Macdonald GJ; Moechars D; Rombouts F; Alexander R; Spurlino J; Van Gool M; Vega JA; Trabanco AA
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7255-60. PubMed ID: 22071305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors.
    Wang YS; Strickland C; Voigt JH; Kennedy ME; Beyer BM; Senior MM; Smith EM; Nechuta TL; Madison VS; Czarniecki M; McKittrick BA; Stamford AW; Parker EM; Hunter JC; Greenlee WJ; Wyss DF
    J Med Chem; 2010 Feb; 53(3):942-50. PubMed ID: 20043700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly potent macrocyclic BACE-1 inhibitors incorporating a hydroxyethylamine core: design, synthesis and X-ray crystal structures of enzyme inhibitor complexes.
    Sandgren V; Agback T; Johansson PO; Lindberg J; Kvarnström I; Samuelsson B; Belda O; Dahlgren A
    Bioorg Med Chem; 2012 Jul; 20(14):4377-89. PubMed ID: 22698785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and preliminary evaluation of peptidomimetic inhibitors of human beta-secretase.
    Niu Y; Wang Y; Zou X; Yang X; Ma C; Lü Y; Zhou B; Yuan Y; Du G; Xu P
    Eur J Med Chem; 2010 May; 45(5):2089-94. PubMed ID: 20153560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a sub-micromolar, non-peptide inhibitor of β-secretase with low neural cytotoxicity through in silico screening.
    Xu W; Chen G; Zhu W; Zuo Z
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5763-6. PubMed ID: 20732815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design and synthesis of novel P2/P3 modified, non-peptidic beta-secretase (BACE-1) inhibitors.
    Hanessian S; Shao Z; Betschart C; Rondeau JM; Neumann U; Tintelnot-Blomley M
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1924-7. PubMed ID: 20172717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE).
    Boy KM; Guernon JM; Shi J; Toyn JH; Meredith JE; Barten DM; Burton CR; Albright CF; Marcinkeviciene J; Good AC; Tebben AJ; Muckelbauer JK; Camac DM; Lentz KA; Bronson JJ; Olson RE; Macor JE; Thompson LA
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6916-24. PubMed ID: 21782431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretase.
    Barrow JC; Stauffer SR; Rittle KE; Ngo PL; Yang Z; Selnick HG; Graham SL; Munshi S; McGaughey GB; Holloway MK; Simon AJ; Price EA; Sankaranarayanan S; Colussi D; Tugusheva K; Lai MT; Espeseth AS; Xu M; Huang Q; Wolfe A; Pietrak B; Zuck P; Levorse DA; Hazuda D; Vacca JP
    J Med Chem; 2008 Oct; 51(20):6259-62. PubMed ID: 18811140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening.
    Yi Mok N; Chadwick J; Kellett KA; Hooper NM; Johnson AP; Fishwick CW
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6770-4. PubMed ID: 19854048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of aminoheterocycles as a novel beta-secretase inhibitor class: pH dependence on binding activity part 1.
    Stachel SJ; Coburn CA; Rush D; Jones KL; Zhu H; Rajapakse H; Graham SL; Simon A; Katharine Holloway M; Allison TJ; Munshi SK; Espeseth AS; Zuck P; Colussi D; Wolfe A; Pietrak BL; Lai MT; Vacca JP
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2977-80. PubMed ID: 19409780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and SAR study of hydroxychalcone inhibitors of human β-secretase (BACE1).
    Ma L; Yang Z; Li C; Zhu Z; Shen X; Hu L
    J Enzyme Inhib Med Chem; 2011 Oct; 26(5):643-8. PubMed ID: 21222511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I--inhibitor design and validation.
    Zhu Z; Sun ZY; Ye Y; Voigt J; Strickland C; Smith EM; Cumming J; Wang L; Wong J; Wang YS; Wyss DF; Chen X; Kuvelkar R; Kennedy ME; Favreau L; Parker E; McKittrick BA; Stamford A; Czarniecki M; Greenlee W; Hunter JC
    J Med Chem; 2010 Feb; 53(3):951-65. PubMed ID: 20043696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apo and inhibitor complex structures of BACE (beta-secretase).
    Patel S; Vuillard L; Cleasby A; Murray CW; Yon J
    J Mol Biol; 2004 Oct; 343(2):407-16. PubMed ID: 15451669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1' substrate binding pocket.
    Jennings LD; Cole DC; Stock JR; Sukhdeo MN; Ellingboe JW; Cowling R; Jin G; Manas ES; Fan KY; Malamas MS; Harrison BL; Jacobsen S; Chopra R; Lohse PA; Moore WJ; O'Donnell MM; Hu Y; Robichaud AJ; Turner MJ; Wagner E; Bard J
    Bioorg Med Chem Lett; 2008 Jan; 18(2):767-71. PubMed ID: 18068983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of potent BACE-1 inhibitors incorporating a hydroxyethylene isostere as central core.
    Wångsell F; Gustafsson K; Kvarnström I; Borkakoti N; Edlund M; Jansson K; Lindberg J; Hallberg A; Rosenquist A; Samuelsson B
    Eur J Med Chem; 2010 Mar; 45(3):870-82. PubMed ID: 20036448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and crystal structure of hydroxyethyl secondary amine-based peptidomimetic inhibitors of human beta-secretase.
    Maillard MC; Hom RK; Benson TE; Moon JB; Mamo S; Bienkowski M; Tomasselli AG; Woods DD; Prince DB; Paddock DJ; Emmons TL; Tucker JA; Dappen MS; Brogley L; Thorsett ED; Jewett N; Sinha S; John V
    J Med Chem; 2007 Feb; 50(4):776-81. PubMed ID: 17300163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential virtual screening approach to the identification of small organic molecules as potential BACE-1 inhibitors.
    Chiriano G; Sartini A; Mancini F; Andrisano V; Bolognesi ML; Roberti M; Recanatini M; Carloni P; Cavalli A
    Chem Biol Drug Des; 2011 Apr; 77(4):268-71. PubMed ID: 21244641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pockets.
    Cole DC; Stock JR; Chopra R; Cowling R; Ellingboe JW; Fan KY; Harrison BL; Hu Y; Jacobsen S; Jennings LD; Jin G; Lohse PA; Malamas MS; Manas ES; Moore WJ; O'Donnell MM; Olland AM; Robichaud AJ; Svenson K; Wu J; Wagner E; Bard J
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1063-6. PubMed ID: 18162398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular docking and structure-activity relationship studies on benzothiazole based non-peptidic BACE-1 inhibitors.
    Xu W; Chen G; Zhu W; Zuo Z
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6203-7. PubMed ID: 20850315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design of novel, potent piperazinone and imidazolidinone BACE1 inhibitors.
    Cumming JN; Le TX; Babu S; Carroll C; Chen X; Favreau L; Gaspari P; Guo T; Hobbs DW; Huang Y; Iserloh U; Kennedy ME; Kuvelkar R; Li G; Lowrie J; McHugh NA; Ozgur L; Pan J; Parker EM; Saionz K; Stamford AW; Strickland C; Tadesse D; Voigt J; Wang L; Wu Y; Zhang L; Zhang Q
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3236-41. PubMed ID: 18468890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.